OOIR: Observatory of International Research

Papers

(The TQCC of Hematology-Oncology Clinics of North America is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)

Article	Citations
Prognostic and Predictive Implications of Cytogenetics and Genomics	103
Autoimmune Hemolytic Anemia: An Old Disease with New Twists	67
Managing First-Line Metastatic Renal Cell Carcinoma	58
Conflict and Access to Health Care	48
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia	48
Insights into Renal Cell Carcinoma with Novel Imaging Approaches	34
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver	32
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia	32
Cancer of the Larynx and Hypopharynx	32
Treatment of High-Risk Gestational Trophoblastic Neoplasia	30
Contents	26
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis	26
Contributors	24
Benefits and Harms of Interception and Early Detection of Cancer	23
Hematology/Oncology Clinics of North America	23
Copyright	22
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer	22
Contributors	22
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer	21
Advances in Gastric Cancer Surgical Management	20
Disparities in Breast Cancer Outcomes and How to Resolve Them	20
Updates in the Management of Warm Autoimmune Hemolytic Anemia	20
The Evolving Landscape of Drug Therapies for Sickle Cell Disease	19
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes	18
Future Directions for Gestational Trophoblastic Disease	17

Advances in Immunotherapy in Esophagogastric Cancer	17
Factor XIII Deficiency	17
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas	16
Forthcoming Issues	16
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia	15
Advances in Surgical Techniques for Lung Cancer	14
Emerging Therapies in β-Thalassemia	14
Inherited Platelet Disorders	14
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma	13
Adult Evans' Syndrome	13
Foreword	13
Contents	13
Advances in Systemic Therapy in Pancreatic Cancer	13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes	13
Clinical Characteristics and Treatment of Histiocytic Disorders in Children	12
Liposarcoma	12
Genomic Alterations in Langerhans Cell Histiocytosis	12
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia	12
Histiocytic Disorders in Pediatric and Adult Patients	12
Red Cell Antigens and Antibodies	11
Forthcoming Issues	11
Clinical Vignettes Part I	11
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors	11
Genes as Medicine	11
Copyright	11
Hereditary Renal Cell Carcinoma Syndromes	11
Genomics of Resistance to Targeted Therapies	10
Malignancies of the Upper Gastrointestinal Tract	10
Evaluation and Management of Bing–Neel Syndrome	10
New Developments in Myeloma	10
Skin Cancer Precursors	10
Copyright	9
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities	9
Patient-Reported Outcomes in Radiation Oncology	9
Gestational Trophoblastic Neoplasia	9
Evolution of Gene Therapy, Historical Perspective	9
High-Risk Non-Melanoma Skin Cancers	9
Contents	9
Forthcoming Issues	8
Advances in the Surgical Management of Esophageal Cancer	8
Bispecific Antibodies in the Treatment of Multiple Myeloma	8
Contents	8
Heavy Ion Particle Therapy in Modern Day Radiation Oncology	8
Local Control in Soft Tissue Sarcomas	8
Copyright	8
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy	8
Radiation-Induced Tissue Regeneration	7
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms	7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma	7
Disparities and Inequities Among Patients with Central Nervous System Tumor	7

Contents	7
Breast Cancer and Lifestyle Factors	7
Melanoma Brain Metastasis	7
Breast Cancer in India	7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer	7
Chronic Lymphocytic Leukemia	6
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers	6
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors	6
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases	6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?	6
FLASH Radiotherapy	6
Clinical Complications and Their Management	6
Copyright	6
Future Directions in Bladder Cancer Treatment and Research—The Patient Advocates’ Perspective	6
Education and Training Models for Remote Learning	6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies	6
Disorders of Fibrinogen and Fibrinolysis	5
Targeted Therapy Innovations for Melanoma	5
Contents	5
Current Perioperative Therapy for Muscle Invasive Bladder Cancer	5
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma	5
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors	5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy	5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma	5
Hemophilia A/B	5
Impact of Clonal Heterogeneity in Multiple Myeloma	5
Ductal Carcinoma In Situ	5
Copyright	5
Early Detection of Precursor Diseases of Multiple Myeloma	5
Merkel Cell Carcinoma	4
Contributors	4
Renal Cell Cancer	4
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)	4
Complications of Autoimmune Hemolytic Anemia	4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings	4
Approach to High-Risk Multiple Myeloma	4
Pathogenic Mechanisms in Thalassemia II	4
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia	4
Local Therapies in Advanced Colorectal Cancer	4
Pathogenic Mechanisms in Thalassemia I	4
Role of Radiation in Treatment of Renal Cell Carcinoma	4
Forthcoming Issues	4
Current Therapy for Metastatic Urothelial Carcinoma	4
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia	4
Genetics and Genomics of Gestational Trophoblastic Disease	4
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis	4
Contributors	4
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing	4
Contents	4
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors	4
Regulatory Aspects of Gene Therapy	4
Remembering the Contributions of Professor David J. Weatherall	4
Immunotherapy-associated Autoimmune Hemolytic Anemia	4
Immune-Pathogenesis of Myeloma	4